Among the upregulated CSIRGs, most were expressed in all of the cell types, including malignant cells (Mal), CD4+ T cells, CD8+ T cells, T cells, NK cells, macrophages cells, B cells, cancer-associated fibroblast (CAF) cells, and endothelial cells. This evidence concerns the gene CD4 and cancer.